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Other names: BRN3A; Brn-3a; FLJ13449; Oct-T1; 
RDC-1 
Location: 13q31.1 
Local order: Gene orientation: minus strand. 




The gene is about 4,468 bases encoded by two exons 
separated by a short intron. 
Transcription 
5', upstream promoter drives expression of longer Brn-
3a transcript encoding for Brn-3a(l) protein which 
includes exons 1 and 2. Regulatory sequences within 
the intron control expression of short Brn-3a transcript 
entirely from exon 2, which encodes Brn-3a(s) protein. 
Protein 
Description 
Protein product for Brn-3a(l) is 423 amino acids with 
estimated molecular weight of about 42.9 kDa whereas 
Brn-3a(s) protein is 339 amino acids; about 32 kDa. 
Expression 
Nervous System: Originally isolated from brain cDNA, 
Brn-3a is expressed in specific neurons of midbrain and 
hindbrain in CNS and in peripheral sensory neurons 
(trigeminal ganglia, dorsal root ganglia, spinal cord). It 
is first seen in neural crest cells that are destind to 
form sensory neurons and expression persists in mature 
neurones. Brn-3a is also expressed in retinal ganglion 
cells and vestibular somatosensory cells, where it 
cooperates with Brn-3b and Brn-3c respectively to 
determine cell fate. 
Non-neuronal cell: Brn-3a is also expressed in T-cells, 
heart, testis, ovary, breast epithelium. 
Cancers: implicated in neuroblastoma, Ewing sarcoma, 




Brn-3a proteins act as transcription factors to regulate 
the expression of target genes, which can alter cell fat . 
In neuron, Brn-3a protects cells from apoptosis (by
transactivating anti-apoptotic genes while repressing 
expression of pro-apoptotic proteins -see below). Brn-
3a also enhances differentiation of neuronal cells in 
vitro and in-vivo by its ability to transactivate multiple 
neuronal target promoters. Brn-3a is required for the
generation of proprioceptors in trigeminal ganglia. 
The POU domain found at the C' terminal end of Brn-
3a proteins is a bipartite DNA binding domain that c n 
recognize and bind with high affinity and specificity to 
specific DNA sequences present in the promoters of 
target genes. DNA consensus sites recognized by Brn-
3a include a core A/T rich octamer sequence e.g. 
ATAATTAAT with the POU-homeodomain (POU-
HD) facilitating high affinity binding, whilst the POU-
specific (POU-s) domain enhances specificity. 
The POU domain of Brn-3a protein also has 
transactivation function and since Brn-3a(l) and Brn-
3a(s) are identical in this region, both proteins can 
regulate specific subsets of target genes that require 
POU domain transactivation function e.g. 
neurofilament, SNAP 25, synaptophysin, Hsp-27.  
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Schematic diagram showing the two isoforms of Brn3-a protein that can be derived from the Brn-3a gene as a result of alternative 
promoter usage (P1 and P2). AD refers to N-terminal activation domain present only in Brn-3a(l). POU domain found at the C' terminal of 
the protein is common to both Brn-3a(l) and Brn-3a(s). 
 
However, some Brn-3a target genes require the N' 
terminal transactivation domain that is found only in 
Brn-3a(l) protein and therefore these target genes can 
only be activated by Brn-3a(l) protein e.g. Bcl-2, Bcl-
XL, alpha-internexin. Other target genes regulated by 
Brn-3a include TrkA, neuroD1 and neuroD4, Nav1.7 
sodium channel, Doppel glycoprotein, iNOS, p53, 
NGFI-A, Hsp-27, tyrosine hydroxylase. Brn-3a also 
auto-regulate its own expression. 
In addition to its direct effects on specific target nes, 
Brn-3a can also alter gene expression by its interac ion 
with other cellular factors. For example, Brn-3a 
interacts physically with p53 protein, and modifies ts 
effects on specific target genes that regulate cell fate. 
Thus Brn-3a cooperates with p53 to increase the 
expression of the cell cycle regulator, p21cip1/waf1 
whilst antagonising p53 mediated expression of pro-
apoptotic target genes, Bax and Noxa. 
Brn-3a other interacting partner includes Rin1 (on 
target gene, Egr1), HIPK1 (alters TrkA expression), 
EWS - Fli1 fusion protein (represses Brn-3a mediate 
effects on survival / differentiation genes). 
In addition to cellular target genes, Brn-3a also controls 
expression of viral genes such as those encoding the 
human papilloma virus (HPV) immediate early E6/E7 
gene (required for HPV transformation of cervical 
cells) by binding to and transactivating the viral 
promoter. It is thought that the ability of Brn-3a to
transactivate this promoter contributes to its effects in 
transformation of cervical cancer cells. 
Homology 
High homology with other POU4 family members in 
the POU domain (C' terminal end of the protein), and in 
the POU4 box (region of homology within the N' 
terminal transactivation domain, present only in Brn-
3a(l)). Family members include mammalian POU4f2 
(Brn-3b), POU4f3 (Brn-3c), drosophila I-POU and 
nematode, unc-86. 
Implicated in 
Normal development of sensory 
neurons in CNS and PNS 
Note: Loss of Brn-3a by homologous recombination in 
mice resulted in significant loss of sensory neurons 
(e.g. in the midbrain, trigeminal ganglia, dorsal root 
ganglia) during development. Mutants die within the 
first day of birth. Studies using cultured neural crest 
cells demonstrate that Brn-3a expressing cells are 
destined for sensory lineage. Brn-3a is required for the 
survival of these cells and achieves this partly by 
inhibiting expression of p53 mediated, pro-apoptotic 
target genes. Neural crest cells cultured from Brn-3a 
knockout mice, undergo significant apoptosis as a 
result of increased expression of p53 pro-apoptotic 
target genes, bax and Noxa. 
Neuroblastomas 
Oncogenesis 
Brn-3a mRNA is significantly reduced in 
neuroblastoma tumour biopsies. Studies undertaken 
using neuroblastoma cell lines showed that Brn-3a is 
expressed at low levels when the cells are actively 
proliferating. However, when cells are induced to cease 
dividing and undergo differentiation, Brn-3a is 
significantly increased in cells. Forced over-expression 
of Brn-3a protects cells from apoptosis but also induces 
differentiation and neurite outgrowth. Therefore, the 
significant decrease of Brn-3 in neuroblastoma tumors 
may contribute to the oncogenic changes in the cells. 
Neuroendocrine tumours 
Oncogenesis 
Brn-3a was shown to be elevated in highly aggressiv 
neuroendocrine tumours SCCL tumours and ACTH 
producing pituitary tumours. 
Ewing sarcoma 
Oncogenesis 
Brn-3a was detected in some Ewing sarcomas, which 
are tumours derived from primitive neural ectodermal 
lineage. These tumours are characterised by 
rearrangement of genes encoding the Ewing sarcoma 
(EWS) protein, and members of the Ets family of 
transcription factors. The most common fusion protein, 
EWS/Fli1, produces cellular transformation. Brn-3a 
interacts with the EWS/Fli1 fusion protein, and this 
interaction prevents Brn-3a mediated transactivation of 
genes required for cell cycle arrest e.g. p21cip1/waf1 
and neurite outgrowth e.g. SNAP-25. 
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Cervical cancer 
Oncogenesis 
Brn-3a is expressed at high levels in high-grade 
cervical intra-epithelial neoplasia (CIN 3) compared to 
normal cervical biopsies. In this context, Brn-3a my 
contribute to tissue formation by binding to regulatory 
regions of Human Papilloma Viruses, HPV-16 and 
HPV18 and regulate expression of their oncogenic E6 
and E7 genes. 
Prostate cancer 
Oncogenesis 
Brn-3a was also detected in prostate cancers with up to 
50% of tumours showing significant increase in 
expression of Brn-3a short isoforms. 
Systemic lupus erythematosus 
Note: Brn-3a is elevated in approximately 43% of 
patients with SLE and this correlates with enhanced 
levels of auto-antibodies to the protein. Increased Brn-
3a also correlates with enhanced expression of HSP 90 
protein in serum of SLE patients. 
References 
He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, 
Rosenfeld MG. Expression of a large family of POU-domain 
regulatory genes in mammalian brain development. Nature 
1989;340(6228):35-41. 
Collum RG, Fisher PE, Datta M, Mellis S, Thiele C, Huebner K, 
Croce CM, Israel MA, Theil T, Moroy T, et al. A Novel POU 
homeodomain gene specifically expressed in cells of the 
developing mammalian nervous system. Nucleic Acids Res 
1992;20(18):4919-4925. 
Lillycrop KA, Budhram VS, Lakin ND, Terrenghi G, Wood JN, 
Polak JM, Latchman DS. A novel POU family transcription 
factor is closely related to Brn-3 but has a distinct expression 
pattern in neuronal cells. Nucleic Acids Res 1992;20(19):5093-
5096. 
Bhargava AK, Li Z, Weissman SM. Differential expression of 
four members of the POU family of proteins in activated and 
phorbol 12-myristate 13-acetate-treated Jurkat T cells. Proc 
Natl Acad Sci USA 1993;90(21):10260-10264. 
Budhram-Mahadeo V, Theil T, Morris PJ, Lillycrop KA, Möröy 
T, Latchman DS. The DNA target site for the Brn-3 POU family 
transcription factors can confer responsiveness to cyclic AMP 
and removal of serum in neuronal cells. Nucleic Acids Res 
1994;22(15):3092-3098. 
Budhram-Mahadeo V, Lillycrop KA, Latchman DS. The levels 
of the antagonistic POU family transcription factors Brn-3a and 
Brn-3b in neuronal cells are regulated in opposite directions by 
serum growth factors. Neurosci Lett 1995;185(1):48-51. 
Budhram-Mahadeo V, Morris PJ, Lakin ND, Theil T, Ching GY, 
Lillycrop KA, Moroy T, Liem RK, Latchman DS. Activation of 
the alpha-internexin promoter by the Brn-3a transcription factor 
is dependent on the N-terminal region of the protein. J Biol 
Chem 1995;270(6):2853-2858. 
Fedtsova NG, Turner EE. Brn-3.0 expression identifies early 
post-mitotic CNS neurons and sensory neural precursors. 
Mech Dev 1995;53(3):291-304. 
Lakin ND, Morris PJ, Theil T, Sato TN, Möröy T, Wilson MC, 
Latchman DS. Regulation of neurite outgrowth and SNAP-25 
gene expression by the Brn-3a transcription factor. J Biol 
Chem 1995;270(26):15858-15863. 
Lillycrop KA, Liu YZ, Theil T, Möröy T, Latchman DS. 
Activation of the herpes simplex virus immediate-early gene 
promoters by neuronally expressed POU family transcription 
factors. Biochem J 1995;307 (Pt 2):581-584. 
Milton NG, Bessis A, Changeux JP, Latchman DS. The 
neuronal nicotinic acetylcholine receptor alpha 2 subunit gene 
promoter is activated by the Brn-3b POU family transcription 
factor and not by Brn-3a or Brn-3c. J Biol Chem 
1995;270(25):15143-15147. 
Budhram-Mahadeo V, Morris PJ, Lakin ND, Dawson SJ, 
Latchman DS. The different activities of the two activation 
domains of the Brn-3a transcription factor are dependent on 
the context of the binding site. J Biol Chem 
1996;271(15):9108-9113. 
Latchman DS. Activation and repression of gene expression by 
POU family transcription factors. Philos Trans R Soc Lond B 
Biol Sci 1996;351(1339):511-515. (Review). 
Liu YZ, Dawson SJ, Latchman DS. Alternative splicing of the 
Brn-3a and Brn-3b transcription factor RNAs is regulated in 
neuronal cells. J Mol Neurosci 1996;7(1):77-85. 
McEvilly RJ, Erkman L, Luo L, Sawchenko PE, Ryan AF, 
Rosenfeld MG. Requirement for Brn-3.0 in differentiation and 
survival of sensory and motor neurons. Nature 
1996;384(6609):574-577. 
Milton NG, Bessis A, Changeux JP, Latchman DS. Differential 
regulation of neuronal nicotinic acetylcholine receptor subunit 
gene promoters by Brn-3 POU family transcription factors. 
Biochem J 1996;317 (Pt 2):419-423. 
Morris PJ, Lakin ND, Dawson SJ, Ryabinin AE, Kilimann MW, 
Wilson MC, Latchman DS. Differential regulation of genes 
encoding synaptic proteins by members of the Brn-3 subfamily 
of POU transcription factors. Brain Res Mol Brain Res 
1996;43(1-2):279-285. 
Smith MD, Latchman DS. The functionally antagonistic POU 
family transcription factors Brn-3a and Brn-3b show opposite 
changes in expression during the growth arrest and 
differentiation of human neuroblastoma cells. Int J Cancer 
1996;67(5):653-660. 
Turner EE, Fedtsova N, Rosenfeld MG. POU-domain factor 
expression in the trigeminal ganglion and implications for 
herpes virus regulation. Neuroreport 1996;7(18):2829-2832. 
Xiang M, Gan L, Zhou L, Klein WH, Nathans J. Targeted 
deletion of the mouse POU domain gene Brn-3a causes 
selective loss of neurons in the brainstem and trigeminal 
ganglion, uncoordinated limb movement, and impaired 
suckling. Proc Natl Acad Sci USA 1996;93(21):11950-11955. 
Leblond-Francillard M, Picon A, Bertagna X, de Keyzer Y. High 
expression of the POU factor Brn3a in aggressive 
neuroendocrine tumors. J Clin Endocrinol Metab 
1997;82(1):89-94. 
Smith MD, Dawson SJ, Latchman DS. The Brn-3a transcription 
factor induces neuronal process outgrowth and the coordinate 
expression of genes encoding synaptic proteins. Mol Cell Biol 
1997;17(1):345-354. 
Smith MD, Morris PJ, Dawson SJ, Schwartz ML, Schlaepfer 
WW, Latchman DS. Coordinate induction of the three 
neurofilament genes by the Brn-3a transcription factor. J Biol 
Chem 1997;272(34):21325-21333. 
Xiang M, Gan L, Li D, Zhou L, Chen ZY, Wagner D, O'Malley 
BW Jr, Klein W, Nathans J. Role of the Brn-3 family of POU-
domain genes in the development of the auditory/vestibular, 
somatosensory, and visual systems. Cold Spring Harb Symp 
Quant Biol 1997;62:325-336. (Review). 
Latchman DS. The Brn-3a transcription factor. Int J Biochem 
Cell Biol 1998;30(11):1153-1157. (Review). 






Atlas Genet Cytogenet Oncol Haematol. 2008;12(4)  323 
Gay RD, Dawson SJ, Murphy WJ, Russell SW, Latchman DS. 
Activation of the iNOS gene promoter by Brn-3 POU family 
transcription factors is dependent upon the octamer motif in the 
promoter. Biochim Biophys Acta 1998;1443(3):315-322. 
Ndisang D, Morris PJ, Chapman C, Ho L., Singer A, Latchman 
DS. The HPV-activating cellular transcription factor Brn-3a is 
overexpressed in CIN3 cervical lesions. J Clin Invest 
1998;101(8):1687-1692. 
Smith MD, Dawson SJ, Boxer LM, Latchman DS. The N-
terminal domain unique to the long form of the Brn-3a 
transcription factor is essential to protect neuronal cells from 
apoptosis and for the activation of Bbcl-2 gene expression. 
Nucleic Acids Res 1998;26(18):4100-4107. 
Wyatt S, Ensor L, Begbie J, Ernfors P, Reichardt LF, Latchman 
DS. NT-3 regulates expression of Brn3a but not Brn3b in 
developing mouse trigeminal sensory neurons. Brain Res Mol 
Brain Res 1998;55(2):254-264. 
Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, 
Boxer LM, Latchman DS. P53 suppresses the activation of the 
Bcl-2 promoter by the Brn-3a POU family transcription factor. J 
Biol Chem 1999;274(21):15237-15244. 
Huang EJ, Zang K, Schmidt A, Saulys A, Xiang M, Reichardt 
LF. POU domain factor Brn-3a controls the differentiation and 
survival of trigeminal neurons by regulating Trk receptor 
expression. Development 1999;126(13):2869-2882. 
Ndisang D, Budhram-Mahadeo V, Latchman DS. The Brn-3a 
transcription factor plays a critical role in regulating human 
papilloma virus gene expression and determining the growth 
characteristics of cervical cancer cells. J Biol Chem 
1999;274(40):28521-28527. 
Smith MD, Ensor EA, Stohl L, Wagner JA, Latchman DS. 
Regulation of NGFI-A (Egr-1) gene expression by the POU 
domain transcription factor Brn-3a. Brain Res Mol Brain Res 
1999;74(1-2):117-125. 
Trieu M, Rhee JM, Fedtsova N, Turner EE. Autoregulatory 
sequences are revealed by complex stability screening of the 
mouse brn-3.0 locus. J Neurosci 1999;19(15):6549-6558. 
Ndisang D, Budhram-Mahadeo V, Singer A, Latchman DS. 
Widespread elevated expression of the human papilloma virus 
(HPV)-activating cellular transcription factor Brn-3a in the 
cervix of women with CIN3 (cervical intraepithelial neoplasia 
stage 3). Clin Sci (Lond) 2000;98(5):601-602. 
Budhram-Mahadeo V, Moore A, Morris PJ, Ward T, Weber B, 
Sassone-Corsi P, Latchman DS. The closely related POU 
family transcription factors Brn-3a and Brn-3b are expressed in 
distinct cell types in the testis. Int J Biochem Cell Biol 
2001;33(10):1027-1039. 
Eng SR, Gratwick K, Rhee JM, Fedtsova N, Gan L, Turner EE. 
Defects in sensory axon growth precede neuronal death in 
Brn3a-deficient mice. J Neurosci 2001;21(2):541-549. 
Ensor E, Smith MD, Latchman DS. The BRN-3A transcription 
factor protects sensory but not sympathetic neurons from 
programmed cell death/apoptosis. J Biol Chem 
2001;276(7):5204-5212. 
Fedtsova N, Turner EE. Signals from the ventral midline and 
isthmus regulate the development of Bn3.0-expressing 
neurons in the midbrain. Mech Dev 2001;105(1-2):129-144. 
Huang EJ, Liu W, Fritzsch B, Bianchi LM, Reichardt lf, Xiang 
M. Brn3a is a transcriptional regulator of soma size, target field 
innervation and axon pathfinding of inner ear sensory neurons. 
Development 2001;128(13):2421-2432. 
Ndisang D, Budhram-Mahadeo V, Pedley B, Latchman DS. 
The Brn-ea transcription factor plays a key role in regulating 
the growth of cervical cancer cells in vivo. Oncogene 
2001;20(35):4899-4903. 
Smith MD, Melton La, Ensor EA, Packham G, Anderson P, 
Kinloch RA, Latchman DS. Brn-3a activates the expression of 
Bcl-x(L) and promotes neuronal survival in vivo as well as in 
vitro. Mol Cell Neurosci 2001;17(3):460-470. 
Budhram-Mahadeo V, Morris PJ, Latchman DS. The Brn-3a 
transcription factor inhibits the pro-apoptotic effect of p53 and 
enhances cell cycle arrest by differentially regulating the 
activity of the p53 target genes encoding Bax and 
p21(CIP1/Waf1). Oncogene 2002;21(39):6123-6131. 
Budhram-Mahadeo V, Morris P, Ndisang D, Irshad S, Lozano 
G, Pedley b, Latchman DS. The Brn-3a POU family 
transcription factor stimulates p53 gene expression in human 
and mouse tumour cells. Neurosci Lett 2002;334(1):1-4. 
Frass B, Vassen L, Moroy T. Gene expression of the POU 
factor Brn-3a is regulated by two different promoters. Biochim 
Biophys Acta 2002;1579(2-3):207-213. 
Ichikawa H, Mo Z, Xiang M, Sugimoto T. Effect of Brn-3a 
deficiency on nociceptors and low-threshold mechanoreceptors 
in the trigeminal ganglion. Brain Res Mol Brain Res 
2002;104(2):240-245. 
Perez-Sanchez C, Budhram-Mahadeo VS, Latchman DS. 
Distinct promoter elements mediate the co-operative effect of 
Brn-3a and p53 on the p21 promoter and their antagonism on 
the Bax promoter. Nucleic Acids Res 2002;30(22):4872-4880. 
Thomas GR, Latchman DS. The pro-oncoprotein EWS 
(Ewing's Sarcoma protein) interacts with the Brn-3a POU 
transcription factor and inhibits its ability to activate 
transcription. Cancer Biol Ther 2002;1(4):428-432. 
Ma L, Lei L, eng SR, Turner E, Parada LF. Brn3a regulation of 
TrkA/NGF receptor expression in developing sensory neurons. 
Development 2003;130(15):3525-3534. 
Calissano M, Ensor E, Brown DR, Latchman DS. Doppel 
expression is regulated by the Brn-3a and Brn-3b transcription 
factors. Neuroreport 2004;15(3):483-486. 
Eng SR, Lanier J, Fedtsova N, Turner EE. Coordinated 
regulation of gene expression by Brn-3a in developing sensory 
ganglia. Development 2004;131(16):3859-3870. 
Farooqui-Kabir SR, Budhram-Mahadeo V, Lewis H, Latchman 
DS, Marber MS, Heads RJ. Regulation of Hsp27 expression 
and cell survival by the POU transcription factor Brn3a. Cell 
Death Differ 2004;11(11):1242-1244. 
Faulkes DJ, Ensor E, Le Rouzic E, Latchman DS. Distinct 
domains of Brn-3a regulate apoptosis and neurite outgrowth in 
vivo. Neuroreport 2004;15(9):1421-1425. 
Gascoyne DM, Thomas GR, Latchman DS. The effects of Brn-
3a on neuronal differentiation and apoptosis are differentially 
modulated by EWS and its oncogenic derivative EWS/Fli-1. 
Oncogene 2004;23(21):3830-3840. 
Hudson CD, Podesta J, Henderson D, Latchman DS, 
Budhram-Mahadeo V. Coexpression of Brn-3a POU protein 
with p53 in a population of neuronal progenitor cells is 
associated with differentiation and protection against 
apoptosis. J Neurosci Res 2004;78(6):803-814. 
Thomas GR, Faulkes DJ, Gascoyne D, Latchman DS. EWS 
differentially activates transcription of the Brn-3a long and short 
isoform mRNAs from distinct promoters. Biochem Biophys Res 
Commun 2004;318(4):1045-1051. 
Calissano M, Faulkes D, Latchman DS. Phosphorylation of the 
Brn-3a transcription factor is modulated during differentiation 
and regulates its functional activity. Brain Res Mol Brain Res 
2005;141(1):10-18. 
Hudson CD, Morris PJ, Latchman DS, Budhram-Mahadeo VS. 
Brn-3a transcription factor blocks p53-mediated activation of 
proapoptotic target genes Noxa and Bax in vitro and in vivo to 
determine cell fate. J Biol Chem 2005;280(12):11851-11858. 
Ichikawa H, Mo Z, Xiang M, Sugimoto T. Brn-3a deficiency 
increases tyrosine hydroxylase-immunoreactive neurons in the 
dorsal root ganglion. Brain Res 2005;1036(1-2):192-195. 






Atlas Genet Cytogenet Oncol Haematol. 2008;12(4)  324 
Ichikawa H, Qiu F, Xiang M, Sugimoto T. Brn-3a is required for 
the generation of proprioceptors in the mesencephalic 
trigeminal tract nucleus. Brain Res 2005;1053(1-2):203-206. 
Ichikawa H, Schultz S, Hollt V, Mo Z, Xiang M, Sugimoto T. 
Effect of Brn-3a deficiency on primary nociceptors in the 
trigeminal ganglion. Neurosci Res 2005;51(4):445-451. 
Ripley BJ, Rahman Ma, Isenberg DA, Latchman DS. Elevated 
expression of the Brn-3a and Brn-3b transcription factors in 
systemic lupus erythematosus correlates with antibodies to 
Brn-3 and overexpression of Hsp90. Arthritis Rheum 
2005;52(4):1171-1179. 
Diss JK, Faulkes DJ, Walker MM, Patel A, Foster CS, 
Budhram-Mahadeo V, Djamgoz MB, Latchman DS. Brn-3a 
neuronal transcription factor functional expression in human 
prostate cancer. Prostate Cancer Prostatic Dis 2006;9(1):83-
91. 
Ndisang D, Faulkes DJ, Gascoyne D, Lee SA, Ripley BJ, 
Sindos M, Singer A, Budhram-Mahadeo V, Cason J, Latchman 
DS. Differential regulation of different human papilloma virus 
variants by the POU family transcription factor Brn-3a. 
Oncogene 2006;25(1):51-60. 
Lanier J, Quina LA, Eng SR, Cox E, Turner EE. Brn3a target 
gene recognition in embryonic sensory neurons. Dev Biol 
2007;302(2):703-716. 
This article should be referenced as such: 
Budhram-Mahadeo V, Latchman DS. POU4F1 (POU class 4 
homeobox 1). Atlas Genet Cytogenet Oncol 
Haematol.2008;12(4):320-324. 
 
 
 
